TY - JOUR
T1 - Acetylation of p53 protein at lysine 120 up-regulates apaf-1 protein and sensitizes the mitochondrial apoptotic pathway
AU - Yun, Tao
AU - Yu, Kaiwen
AU - Yan, Shuang Shuang
AU - Cui, Yifan
AU - Wang, Zixi
AU - Ren, Huiyu
AU - Chen, She
AU - Li, Lin
AU - Liu, Xiaoyun
AU - Fang, Min
AU - Jiang, Xuejun
N1 - Funding Information:
This work was supported by National Basic Program of China 973 Program Grant (2013CB910104), National Science Foundation of China Grant 31271524, a startup fund from Peking University, National Institutes of Health Grants R01CA166413 and R01GM113013, and Memorial Sloan Kettering Cancer Center Support Grant/Core Grant P30 CA008748
Publisher Copyright:
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.
PY - 2016/4/1
Y1 - 2016/4/1
N2 - The p53 tumor suppressor controls cell growth, metabolism, and death by regulating the transcription of various target genes. The target-specific transcriptional activity of p53 is highly regulated. Here we demonstrate that acetylation of p53 at Lys-120 up-regulates its transcriptional activity toward Apaf-1, a core component in the mitochondrial apoptotic pathway, and thus sensitizes caspase activation and apoptosis. We found that histone deacetylase (HDAC) inhibitors, including butyrate, augment Lys-120 acetylation of p53 and thus Apaf-1 expression by inhibiting HDAC1. In p53-null cells, transfection of wild- Type but not K120R mutant p53 can restore the p53-dependent sensitivity to butyrate. Strikingly, transfection of acetylation-mimicking K120Q mutant p53 is sufficient to up-regulates Apaf-1 in a manner independent of butyrate treatment. Therefore,HDAC inhibitors can induce p53 acetylation at lysine 120, which in turn enhances mitochondrion-mediated apoptosis through transcriptional up-regulation of Apaf-1.
AB - The p53 tumor suppressor controls cell growth, metabolism, and death by regulating the transcription of various target genes. The target-specific transcriptional activity of p53 is highly regulated. Here we demonstrate that acetylation of p53 at Lys-120 up-regulates its transcriptional activity toward Apaf-1, a core component in the mitochondrial apoptotic pathway, and thus sensitizes caspase activation and apoptosis. We found that histone deacetylase (HDAC) inhibitors, including butyrate, augment Lys-120 acetylation of p53 and thus Apaf-1 expression by inhibiting HDAC1. In p53-null cells, transfection of wild- Type but not K120R mutant p53 can restore the p53-dependent sensitivity to butyrate. Strikingly, transfection of acetylation-mimicking K120Q mutant p53 is sufficient to up-regulates Apaf-1 in a manner independent of butyrate treatment. Therefore,HDAC inhibitors can induce p53 acetylation at lysine 120, which in turn enhances mitochondrion-mediated apoptosis through transcriptional up-regulation of Apaf-1.
UR - http://www.scopus.com/inward/record.url?scp=84965145388&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84965145388&partnerID=8YFLogxK
U2 - 10.1074/jbc.M115.706341
DO - 10.1074/jbc.M115.706341
M3 - Article
C2 - 26851285
AN - SCOPUS:84965145388
SN - 0021-9258
VL - 291
SP - 7386
EP - 7395
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 14
ER -